{
  "docId": "019de072-1de2-7119-a555-9ff409e7e548",
  "docSlug": "506aa41f1d83c0fffcc1a747d59c4e2b",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 86 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 27,
  "pageCount": 86,
  "prevPage": 26,
  "nextPage": 28,
  "slideType": "other",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Uses a causal chain structure to link strategic actions to financial outcomes.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de072-1de2-7119-a555-9ff409e7e548/27",
  "deckHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548",
  "deckJsonHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548.json",
  "deckAnchorHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548#slide-27",
  "components": [
    {
      "bbox": {
        "h": 0.23,
        "w": 0.23,
        "x": 0.715,
        "y": 0.135
      },
      "kind": "callout",
      "text": "$100M+ brand; 120%+ TRx growth since acquisition",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74647e79-1109-475b-8a9c-62580b36a7e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.55,
        "x": 0.32,
        "y": 0.52
      },
      "kind": "chart",
      "text": "TRULANCE® TRx Trend",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aca8a493-5e0b-4798-bb46-6d3e491d207a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.15,
        "x": 0.13,
        "y": 0.54
      },
      "kind": "image",
      "text": "Trulance bottle",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d622dac-477c-4aba-9b50-5d5f70021f7a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.03,
        "y": 0.21
      },
      "kind": "list",
      "text": "March 2019: BHC acquired certain assets of Synergy Pharmaceuticals, which included TRULANCE®, for $180M",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0eb0fadb-d399-4fc7-a349-9b5be0ed189c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.33,
        "x": 0.18,
        "y": 0.18
      },
      "kind": "list",
      "text": "Improved Market Access: Expanded access for TRULANCE® across Commercial and Medicare Part D; Removed payer restrictions and/or reduced patient copays. Improved Targeting and Grew Footprint: Increased sales reps detailing TRULANCE®; Leveraged existing XIFAXAN® relationships in GI and PCP to enhance the opportunity for TRULANCE®",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "80dd34c1-d672-4fb7-a66c-eedc9a6f70b7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.68,
        "x": 0.02,
        "y": 0.03
      },
      "kind": "title",
      "text": "TRULANCE®: Established a $100M+ Brand³",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1cbef70-bae4-4082-8c13-8c8092bdfcb2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Big Idea Formula",
      "slug": "big-idea-formula",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "6964a93f-7057-4ab8-a784-5f1a0d5d80e5",
      "evidence": "The slide highlights that TRULANCE has been established as a '$100M+ Brand³' with '120%+ TRx growth since acquisition'.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "causal-chain",
      "slug": null,
      "matchId": "095d0062-3d65-45d9-82f1-1b7b92b63d07",
      "evidence": "The slide explicitly links strategic actions (Market Access, Targeting) to outcomes (Growth) using an arrow diagram.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 31,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "44aa48cc-528a-43bd-80b7-2f1179845599",
      "evidence": "The presentation provides an overview of the company's financial results and business performance, highlighting opportunities for growth",
      "position": 1,
      "objective": "What are the opportunities for quick wins and big bets?",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}